Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Sell
25,525
-4,105
-14% -$65.1K ﹤0.01% 733
2026
Q1
$507K Buy
29,630
+4,288
+17% +$79.6K 0.01% 527
2025
Q4
$514K Buy
25,342
+360
+1% +$7.81K 0.01% 496
2025
Q3
$585K Buy
24,982
+120
+0.5% +$2.41K 0.01% 452
2025
Q2
$445K Buy
24,862
+2,064
+9% +$40.3K 0.01% 526
2025
Q1
$472K Buy
22,798
+1,151
+5% +$20.7K 0.01% 461
2024
Q4
$256K Buy
21,647
+4,105
+23% +$50.8K ﹤0.01% 667
2024
Q3
$214K Buy
17,542
+4,335
+33% +$35.9K ﹤0.01% 730
2024
Q2
$96.8K Sell
13,207
-6,726
-34% -$53.1K ﹤0.01% 728
2024
Q1
$153K Buy
19,933
+6,376
+47% +$61.8K ﹤0.01% 692
2023
Q4
$198K Buy
13,557
+1,729
+15% +$27.5K ﹤0.01% 625
2023
Q3
$217K Buy
11,828
+437
+4% +$7.41K 0.01% 535
2023
Q2
$153K Buy
+11,391
New +$112K ﹤0.01% 566

Other funds holding XPEV

Ballentine Partners's XPEV Position: Q2 2026 in Review

Ballentine Partners reduced its XPeng (XPEV) stake by 14% in Q2 2026, selling an estimated $65.1K and leaving 25,525 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Ballentine Partners first reported a position in XPEV in Q2 2023 and has held it in 13 quarters since. The position peaked at $585K in Q3 2025. 15 funds tracked by Wall St. Rank hold XPEV as of Q2 2026.

  • Ballentine Partners held 25,525 shares of XPeng worth $338K as of Q2 2026.
  • Ballentine Partners sold 4,105 XPeng shares in Q2 2026, an estimated $65.1K.
  • XPeng made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #733 holding.
  • Ballentine Partners first reported a position in XPeng in Q2 2023 and has held it in 13 quarters since.
  • Ballentine Partners's XPeng position peaked at $585K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held XPeng as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.